Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · January 29, 2018

Inpatient DM2 Management in Setting of Sickle Cell Anemia and High Dose Steroids

 Anika Anam MD
Written by

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • MUHAMMAD SHOAIB ZAIDI

    Jun 19, 2018

    I would like to keep the patient on Regular insulin infusion to control her blood glucose & reduce glucose toxicity rapidly & for correctly estimating her 24 hours insulin requirement. Once her blood glucose is under reasonable control, then fixed dose basal & bolus insulins can be commenced.
    Thanks.

  • Dec 24, 2024

    Pending Moderator approval.
    Delete

Further Reading